Bristol-Myers Squibb (BMY) Deal for Celgene (CELG) Will Likely Go Through - Barclays

March 22, 2019 9:33 AM
Barclays analyst Geoff Meacham sees Bristol-Myers Squibb (NYSE: BMY) acquisition of Celgene (NASDAQ: CELG) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Mergers and Acquisitions

Next Articles